Similar Papers

Paper Title
Journal
Date
Author
EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure
Katayoun Rezvani ... Richard Szydlo
Biology of Blood and Marrow Transplantation | VOL. 18
Katayoun Rezvani, et. al.Katayoun Rezvani ... Richard Szydlo
30 Jun 2011
Clinical and Immunological Factors Associated with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis Patients
Daehun Kwag ... Gi-June Min
Blood | VOL. 142
Daehun Kwag, et. al.Daehun Kwag ... Gi-June Min
28 Nov 2023
Self-Destructive Behavior among Full-Donor Blood and Marrow Grafts and the Association with Long-Term Graft Function
Richard F Olsson
Biology of Blood and Marrow Transplantation | VOL. 24
Richard F OlssonRichard F Olsson
20 Nov 2017
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens
Marie Detrait ... Mauricette Michallet
Experimental Hematology | VOL. 40
Marie Detrait, et. al.Marie Detrait ... Mauricette Michallet
12 Jun 2012
View more papers

More From: Transplantation and Cellular Therapy

Paper Title
Journal
Date
Author
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for children with chronic GVHD after Hematopoietic Cell Transplantation.
Saldaña Bj Dávila ... K M Williams
Transplantation and cellular therapy | VOL. -
Saldaña Bj Dávila, et. al.Saldaña Bj Dávila ... K M Williams
22 Jan 2025
Prolonged neurologic symptoms following immune effector cell-associated neurotoxicity syndrome in patients with large B cell lymphoma treated with chimeric antigen receptor-modified T cell therapy.
Luke Maillie ... Daniel J Landsburg
Transplantation and cellular therapy | VOL. -
Luke Maillie, et. al.Luke Maillie ... Daniel J Landsburg
21 Jan 2025
Low Survival Due to Higher Risk of Relapse and Nonrelapse Mortality After Allogeneic HSCT in ATL Compared with AML and ALL.
Shohei Tomori ... Makoto Yoshimitsu
Transplantation and cellular therapy | VOL. -
Shohei Tomori, et. al.Shohei Tomori ... Makoto Yoshimitsu
17 Jan 2025
Refining Risk Stratification for B-cell Precursor Adult Acute Lymphoblastic Leukemia Treated With a Pediatric-inspired Regimen by Combining IKZF1 Deletion and Minimal Residual Disease.
Shiyu Deng ... Hongsheng Zhou
Transplantation and cellular therapy | VOL. -
Shiyu Deng, et. al.Shiyu Deng ... Hongsheng Zhou
09 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.